ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

AAM. 2025; 14(4): 421-433


Review on therapeutic uses of Amla (Phyllanthus emblica or Emblica officinalis) with its phytochemical constituents in different kind of extracts.

Shekhar Kumar Sinoria, Kusum Singh.



Abstract
Download PDF Cited by 0 ArticlesPost

The common name for Phyllanthus emblica L., often known as Emblica officinalis, is Indian gooseberry. P. emblica has been widely employed in Ayurveda for its medicinal properties as well as for its edible (tonic) plants. Due to its high nutritional content, Phyllanthus emblica may be a significant dietary source of minerals, amino acids, and vitamin C. Additionally, the plant includes tannins, phenolic compounds, curcuminoids, rutin, phyllembelin, phyllembelic acid, and emblicol. Every part of the plant is used medicinally, but the fruit is particularly valued for its strong properties as a potent rasayana. Previous reports have detailed P. emblica's diverse pharmacological potential, which includes antioxidant activity, hepatoprotective activity, anti-inflammatory activity, antimicrobial activity, anticarcinogenic and antimutagenic activity, cytoprotective activity, immunomodulator activity, and antihyperglycemic and antilipidimic properties when used alone or in combination with other ingredients. To fully explore P. emblica's wide range of medicinal effects, scientific proof of its several additional Ayurvedic potentials is still pending. In light of this, we attempted to examine all available data on P. emblica in this review, including its therapeutic uses and phytochemistry.

Key words: Phyllanthus emblica, Emblica officinalis and phytochemicals.







Bibliomed Article Statistics

23
19
32
35
25
12
15
6
R
E
A
D
S

35

41

48

96

66

81

39

11
D
O
W
N
L
O
A
D
S
1112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.